_id
6911b13fccc777a4e85d5f01
Ticker
FHTX
Name
Foghorn Therapeutics Inc
Exchange
NASDAQ
Address
500 Technology Square, Cambridge, MA, United States, 02139
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://foghorntx.com
Description
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is also developing therapies for mutant cancers, such as androgen receptor, positive prostate cancer, bladder cancer, Non-Small Cell Lung (NSCLC), as well as various lymphomas and leukemias; melanoma, endometrial, gastric, breast, colorectal, and pancreatic cancers; and dependent cancers, including prostate cancer and diffuse large b-cell lymphoma. The company has collaboration agreement with Eli Lilly and Company for developing FHD-909, a selective ATPase inhibitor of BRM. Foghorn Therapeutics Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Last Close
4.48
Volume
39979
Current Price
4.44
Change
-0.8928571428571435
Last Updated
2025-11-30T18:43:33.984Z
Image
data:image/webp;base64,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
Ipo Date
2020-10-23T00:00:00.000Z
Market Cap
268618624
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.863
Sentiment Sources
1
Rating
4.5
Target Price
11.7143
Strong Buy
5
Buy
2
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
8153000
Cost Of Revenue
20002000
Gross Profit
-11849000
Operating Expenses
6652000
Operating Income
-18501000
Interest Expense
-
Pretax Income
-15849000
Net Income
-15849000
Eps
-0.25145451020686527
Dividends Per Share
-
Shares Outstanding
56551289
Income Tax Expense
-
EBITDA
-14997000
Operating Margin
-226.92260517600883
Total Other Income Expense Net
2652000
Cash
89334000
Short Term Investments
90944000
Receivables
-
Inventories
-
Total Current Assets
184117000
Property Plant Equipment
18840000
Total Assets
204962000
Payables
3212000
Short Term Debt
6755000
Long Term Debt
-
Total Liabilities
294620000
Equity
-89658000
Depreciation
900000
Change In Working Capital
-6936000
Cash From Operations
-18860000
Capital Expenditures
0
Cash From Investing
35573000
Cash From Financing
49000
Net Change In Cash
16762000
PE
-
PB
-3.12130608445426
ROE
17.67717325838185
ROA
-7.732652881997638
FCF
-18860000
Fcf Percent
-2.313258923095793
Piotroski FScore
0
Health Score
28
Deep Value Investing Score
2
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
2.5
Growth Investing Score
2
Momentum Investing Score
2.5
Net Net Investing Score
1
Quality Investing Score
2
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
8153000
Quarters > 0 > income Statement > cost Of Revenue
20002000
Quarters > 0 > income Statement > gross Profit
-11849000
Quarters > 0 > income Statement > operating Expenses
6652000
Quarters > 0 > income Statement > operating Income
-18501000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-15849000
Quarters > 0 > income Statement > net Income
-15849000
Quarters > 0 > income Statement > eps
-0.25145451020686527
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
63029293
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-14997000
Quarters > 0 > income Statement > operating Margin
-226.92260517600883
Quarters > 0 > income Statement > total Other Income Expense Net
2652000
Quarters > 0 > balance Sheet > cash
89334000
Quarters > 0 > balance Sheet > short Term Investments
90944000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
184117000
Quarters > 0 > balance Sheet > property Plant Equipment
18840000
Quarters > 0 > balance Sheet > total Assets
204962000
Quarters > 0 > balance Sheet > payables
3212000
Quarters > 0 > balance Sheet > short Term Debt
6755000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
294620000
Quarters > 0 > balance Sheet > equity
-89658000
Quarters > 0 > cash Flow > net Income
-15849000
Quarters > 0 > cash Flow > depreciation
900000
Quarters > 0 > cash Flow > change In Working Capital
-6936000
Quarters > 0 > cash Flow > cash From Operations
-18860000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
35573000
Quarters > 0 > cash Flow > cash From Financing
49000
Quarters > 0 > cash Flow > net Change In Cash
16762000
Quarters > 0 > ratios > PE
-0.25145451020686527
Quarters > 0 > ratios > PB
-3.12130608445426
Quarters > 0 > ratios > ROE
17.67717325838185
Quarters > 0 > ratios > ROA
-7.732652881997638
Quarters > 0 > ratios > FCF
-18860000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-2.313258923095793
Quarters > 0 > health Score
28
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
7557000
Quarters > 1 > income Statement > cost Of Revenue
900000
Quarters > 1 > income Statement > gross Profit
6657000
Quarters > 1 > income Statement > operating Expenses
27754000
Quarters > 1 > income Statement > operating Income
-21097000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-17936000
Quarters > 1 > income Statement > net Income
-17936000
Quarters > 1 > income Statement > eps
-0.28479687556740846
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
62978219
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-17036000
Quarters > 1 > income Statement > operating Margin
-279.17162895328835
Quarters > 1 > income Statement > total Other Income Expense Net
3161000
Quarters > 1 > balance Sheet > cash
72572000
Quarters > 1 > balance Sheet > short Term Investments
126093000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
203842000
Quarters > 1 > balance Sheet > property Plant Equipment
20388000
Quarters > 1 > balance Sheet > total Assets
226236000
Quarters > 1 > balance Sheet > payables
3322000
Quarters > 1 > balance Sheet > short Term Debt
6176000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
302895000
Quarters > 1 > balance Sheet > equity
-76659000
Quarters > 1 > cash Flow > net Income
-17936000
Quarters > 1 > cash Flow > depreciation
851000
Quarters > 1 > cash Flow > change In Working Capital
-7720000
Quarters > 1 > cash Flow > cash From Operations
-21000000
Quarters > 1 > cash Flow > capital Expenditures
22000
Quarters > 1 > cash Flow > cash From Investing
33834000
Quarters > 1 > cash Flow > cash From Financing
254000
Quarters > 1 > cash Flow > net Change In Cash
12796000
Quarters > 1 > ratios > PE
-0.28479687556740846
Quarters > 1 > ratios > PB
-3.647625097640199
Quarters > 1 > ratios > ROE
23.397122320927746
Quarters > 1 > ratios > ROA
-7.928004384801711
Quarters > 1 > ratios > FCF
-21022000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-2.7817917162895327
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
5952000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
5952000
Quarters > 2 > income Statement > operating Expenses
28865000
Quarters > 2 > income Statement > operating Income
-22913000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-18834000
Quarters > 2 > income Statement > net Income
-18834000
Quarters > 2 > income Statement > eps
-0.2996721983294699
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
62848673
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-22086000
Quarters > 2 > income Statement > operating Margin
-384.9630376344086
Quarters > 2 > income Statement > total Other Income Expense Net
4079000
Quarters > 2 > balance Sheet > cash
61026000
Quarters > 2 > balance Sheet > short Term Investments
159561000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
225416000
Quarters > 2 > balance Sheet > property Plant Equipment
31543000
Quarters > 2 > balance Sheet > total Assets
258691000
Quarters > 2 > balance Sheet > payables
4069000
Quarters > 2 > balance Sheet > short Term Debt
9114000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
320343000
Quarters > 2 > balance Sheet > equity
-61652000
Quarters > 2 > cash Flow > net Income
-18834000
Quarters > 2 > cash Flow > depreciation
827000
Quarters > 2 > cash Flow > change In Working Capital
-9284000
Quarters > 2 > cash Flow > cash From Operations
-23968000
Quarters > 2 > cash Flow > capital Expenditures
28000
Quarters > 2 > cash Flow > cash From Investing
29401000
Quarters > 2 > cash Flow > cash From Financing
139000
Quarters > 2 > cash Flow > net Change In Cash
5572000
Quarters > 2 > ratios > PE
-0.2996721983294699
Quarters > 2 > ratios > PB
-4.526180953091546
Quarters > 2 > ratios > ROE
30.548887302926104
Quarters > 2 > ratios > ROA
-7.280500674549946
Quarters > 2 > ratios > FCF
-23996000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-4.031586021505376
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
2856000
Quarters > 3 > income Statement > cost Of Revenue
761000
Quarters > 3 > income Statement > gross Profit
2856000
Quarters > 3 > income Statement > operating Expenses
26861000
Quarters > 3 > income Statement > operating Income
-24005000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-19503000
Quarters > 3 > income Statement > net Income
-19503000
Quarters > 3 > income Statement > eps
-0.3115353474014473
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
62602848
Quarters > 3 > income Statement > income Tax Expense
-791724
Quarters > 3 > income Statement > EBITDA
-23244000
Quarters > 3 > income Statement > operating Margin
-840.5112044817928
Quarters > 3 > income Statement > total Other Income Expense Net
4502000
Quarters > 3 > balance Sheet > cash
55454000
Quarters > 3 > balance Sheet > short Term Investments
188293000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
249601000
Quarters > 3 > balance Sheet > property Plant Equipment
32605000
Quarters > 3 > balance Sheet > total Assets
283982000
Quarters > 3 > balance Sheet > payables
3785000
Quarters > 3 > balance Sheet > short Term Debt
9067000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
329510000
Quarters > 3 > balance Sheet > equity
-45528000
Quarters > 3 > cash Flow > net Income
-19503000
Quarters > 3 > cash Flow > depreciation
761000
Quarters > 3 > cash Flow > change In Working Capital
-8119000
Quarters > 3 > cash Flow > cash From Operations
-24519000
Quarters > 3 > cash Flow > capital Expenditures
479000
Quarters > 3 > cash Flow > cash From Investing
22291000
Quarters > 3 > cash Flow > cash From Financing
4000
Quarters > 3 > cash Flow > net Change In Cash
-2224000
Quarters > 3 > ratios > PE
-0.3115353474014473
Quarters > 3 > ratios > PB
-6.105180221402215
Quarters > 3 > ratios > ROE
42.83737480231945
Quarters > 3 > ratios > ROA
-6.867688797177286
Quarters > 3 > ratios > FCF
-24998000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-8.75280112044818
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
22602000
Annuals > 0 > income Statement > cost Of Revenue
3120000
Annuals > 0 > income Statement > gross Profit
22602000
Annuals > 0 > income Statement > operating Expenses
125285000
Annuals > 0 > income Statement > operating Income
-102683000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-86620000
Annuals > 0 > income Statement > net Income
-86620000
Annuals > 0 > income Statement > eps
-1.577794101767756
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
54899432
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-97165000
Annuals > 0 > income Statement > operating Margin
-454.3093531545881
Annuals > 0 > income Statement > total Other Income Expense Net
16063000
Annuals > 0 > balance Sheet > cash
55454000
Annuals > 0 > balance Sheet > short Term Investments
188293000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
249601000
Annuals > 0 > balance Sheet > property Plant Equipment
32605000
Annuals > 0 > balance Sheet > total Assets
283982000
Annuals > 0 > balance Sheet > payables
3785000
Annuals > 0 > balance Sheet > short Term Debt
9067000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
329510000
Annuals > 0 > balance Sheet > equity
-45528000
Annuals > 0 > cash Flow > net Income
-86620000
Annuals > 0 > cash Flow > depreciation
3120000
Annuals > 0 > cash Flow > change In Working Capital
-32266000
Annuals > 0 > cash Flow > cash From Operations
-100406000
Annuals > 0 > cash Flow > capital Expenditures
906000
Annuals > 0 > cash Flow > cash From Investing
-29904000
Annuals > 0 > cash Flow > cash From Financing
105428000
Annuals > 0 > cash Flow > net Change In Cash
-24882000
Annuals > 0 > ratios > PE
-1.577794101767756
Annuals > 0 > ratios > PB
-5.727734624846248
Annuals > 0 > ratios > ROE
190.2565454225971
Annuals > 0 > ratios > ROA
-30.50193322111965
Annuals > 0 > ratios > FCF
-101312000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-4.482435182727192
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
34155000
Annuals > 1 > income Statement > cost Of Revenue
109689000
Annuals > 1 > income Statement > gross Profit
34155000
Annuals > 1 > income Statement > operating Expenses
142061000
Annuals > 1 > income Statement > operating Income
-107906000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-94200000
Annuals > 1 > income Statement > net Income
-98426000
Annuals > 1 > income Statement > eps
-2.344900773527079
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
41974484
Annuals > 1 > income Statement > income Tax Expense
4226000
Annuals > 1 > income Statement > EBITDA
-104455000
Annuals > 1 > income Statement > operating Margin
-315.93031766944813
Annuals > 1 > income Statement > total Other Income Expense Net
13706000
Annuals > 1 > balance Sheet > cash
80336000
Annuals > 1 > balance Sheet > short Term Investments
153721000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
240181000
Annuals > 1 > balance Sheet > property Plant Equipment
42912000
Annuals > 1 > balance Sheet > total Assets
285916000
Annuals > 1 > balance Sheet > payables
6260000
Annuals > 1 > balance Sheet > short Term Debt
8518000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
363106000
Annuals > 1 > balance Sheet > equity
-77190000
Annuals > 1 > cash Flow > net Income
-98426000
Annuals > 1 > cash Flow > depreciation
3451000
Annuals > 1 > cash Flow > change In Working Capital
-41879000
Annuals > 1 > cash Flow > cash From Operations
-118106000
Annuals > 1 > cash Flow > capital Expenditures
1224000
Annuals > 1 > cash Flow > cash From Investing
144450000
Annuals > 1 > cash Flow > cash From Financing
1778000
Annuals > 1 > cash Flow > net Change In Cash
28122000
Annuals > 1 > ratios > PE
-2.344900773527079
Annuals > 1 > ratios > PB
-2.5829615105583623
Annuals > 1 > ratios > ROE
127.51133566524162
Annuals > 1 > ratios > ROA
-34.42479609395767
Annuals > 1 > ratios > FCF
-119330000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-3.493778363343581
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
19228000
Annuals > 2 > income Statement > cost Of Revenue
19228
Annuals > 2 > income Statement > gross Profit
19208772
Annuals > 2 > income Statement > operating Expenses
136365000
Annuals > 2 > income Statement > operating Income
-117137000
Annuals > 2 > income Statement > interest Expense
11567745
Annuals > 2 > income Statement > pretax Income
-108882000
Annuals > 2 > income Statement > net Income
-108873745
Annuals > 2 > income Statement > eps
-2.617696413585942
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
41591433
Annuals > 2 > income Statement > income Tax Expense
-8255
Annuals > 2 > income Statement > EBITDA
-113816000
Annuals > 2 > income Statement > operating Margin
-609.2001248179738
Annuals > 2 > income Statement > total Other Income Expense Net
8255000
Annuals > 2 > balance Sheet > cash
52214000
Annuals > 2 > balance Sheet > short Term Investments
293584000
Annuals > 2 > balance Sheet > receivables
2379000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
351399000
Annuals > 2 > balance Sheet > property Plant Equipment
49397000
Annuals > 2 > balance Sheet > total Assets
404883000
Annuals > 2 > balance Sheet > payables
5414000
Annuals > 2 > balance Sheet > short Term Debt
5970000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
404771000
Annuals > 2 > balance Sheet > equity
112000
Annuals > 2 > cash Flow > net Income
-108882000
Annuals > 2 > cash Flow > depreciation
7901000
Annuals > 2 > cash Flow > change In Working Capital
281546000
Annuals > 2 > cash Flow > cash From Operations
193612000
Annuals > 2 > cash Flow > capital Expenditures
1210000
Annuals > 2 > cash Flow > cash From Investing
-244322000
Annuals > 2 > cash Flow > cash From Financing
1763000
Annuals > 2 > cash Flow > net Change In Cash
-48922000
Annuals > 2 > ratios > PE
-2.617696413585942
Annuals > 2 > ratios > PB
1763.9223816964284
Annuals > 2 > ratios > ROE
-97208.70089285714
Annuals > 2 > ratios > ROA
-26.89017444545708
Annuals > 2 > ratios > FCF
192402000
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
10.006344913667569
Annuals > 2 > health Score
28
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
1319000
Annuals > 3 > income Statement > cost Of Revenue
7515000
Annuals > 3 > income Statement > gross Profit
1319000
Annuals > 3 > income Statement > operating Expenses
102053000
Annuals > 3 > income Statement > operating Income
-100734000
Annuals > 3 > income Statement > interest Expense
1906000
Annuals > 3 > income Statement > pretax Income
-101320000
Annuals > 3 > income Statement > net Income
-101320000
Annuals > 3 > income Statement > eps
-2.7257700710715222
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
37171147
Annuals > 3 > income Statement > income Tax Expense
1906000
Annuals > 3 > income Statement > EBITDA
-96187000
Annuals > 3 > income Statement > operating Margin
-7637.149355572403
Annuals > 3 > income Statement > total Other Income Expense Net
-586000
Annuals > 3 > balance Sheet > cash
101136000
Annuals > 3 > balance Sheet > short Term Investments
53153000
Annuals > 3 > balance Sheet > receivables
300000000
Annuals > 3 > balance Sheet > inventories
-353153000
Annuals > 3 > balance Sheet > total Current Assets
459562000
Annuals > 3 > balance Sheet > property Plant Equipment
56079000
Annuals > 3 > balance Sheet > total Assets
519774000
Annuals > 3 > balance Sheet > payables
3819000
Annuals > 3 > balance Sheet > short Term Debt
6994000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
422903000
Annuals > 3 > balance Sheet > equity
96871000
Annuals > 3 > cash Flow > net Income
-101320000
Annuals > 3 > cash Flow > depreciation
3227000
Annuals > 3 > cash Flow > change In Working Capital
33441000
Annuals > 3 > cash Flow > cash From Operations
-50250000
Annuals > 3 > cash Flow > capital Expenditures
3313000
Annuals > 3 > cash Flow > cash From Investing
36173000
Annuals > 3 > cash Flow > cash From Financing
22418000
Annuals > 3 > cash Flow > net Change In Cash
8341000
Annuals > 3 > ratios > PE
-2.7257700710715222
Annuals > 3 > ratios > PB
1.822660530499324
Annuals > 3 > ratios > ROE
-104.59270576333475
Annuals > 3 > ratios > ROA
-19.493087380284507
Annuals > 3 > ratios > FCF
-53563000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-40.608794541319185
Annuals > 3 > health Score
17
Valuation > metrics > PE
-0.25145451020686527
Valuation > metrics > PB
-3.12130608445426
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
17.67717325838185
Profitability > metrics > ROA
-8.608113319248087
Profitability > metrics > Net Margin
-1.943947013369312
Profitability > final Score
35
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-21.714788732394368
Risk > final Score
-57
Risk > verdict
High
Liquidity > metrics > Current Ratio
18.472659777264976
Liquidity > metrics > Quick Ratio
18.472659777264976
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
-64
Prev Risks > 1
2
Prev Risks > 2
4
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:28:45.064Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-05
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.2571
Earnings History > 0 > eps Difference
0.2571
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-05
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.25
Earnings History > 1 > eps Estimate
-0.3333
Earnings History > 1 > eps Difference
0.0833
Earnings History > 1 > surprise Percent
24.9925
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-05
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.28
Earnings History > 2 > eps Estimate
-0.3514
Earnings History > 2 > eps Difference
0.0714
Earnings History > 2 > surprise Percent
20.3187
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-05
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.3
Earnings History > 3 > eps Estimate
-0.29
Earnings History > 3 > eps Difference
-0.01
Earnings History > 3 > surprise Percent
-3.4483
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-05
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.3
Earnings History > 4 > eps Estimate
-0.285
Earnings History > 4 > eps Difference
-0.015
Earnings History > 4 > surprise Percent
-5.2632
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-10-31
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.31
Earnings History > 5 > eps Estimate
-0.44
Earnings History > 5 > eps Difference
0.13
Earnings History > 5 > surprise Percent
29.5455
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-08
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.45
Earnings History > 6 > eps Estimate
-0.65
Earnings History > 6 > eps Difference
0.2
Earnings History > 6 > surprise Percent
30.7692
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-06
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.59
Earnings History > 7 > eps Estimate
-0.63
Earnings History > 7 > eps Difference
0.04
Earnings History > 7 > surprise Percent
6.3492
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-07
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.57
Earnings History > 8 > eps Estimate
-0.76
Earnings History > 8 > eps Difference
0.19
Earnings History > 8 > surprise Percent
25
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-02
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.34
Earnings History > 9 > eps Estimate
-0.75
Earnings History > 9 > eps Difference
0.41
Earnings History > 9 > surprise Percent
54.6667
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-04
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.7
Earnings History > 10 > eps Estimate
-0.73
Earnings History > 10 > eps Difference
0.03
Earnings History > 10 > surprise Percent
4.1096
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-08
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.73
Earnings History > 11 > eps Estimate
-0.72
Earnings History > 11 > eps Difference
-0.01
Earnings History > 11 > surprise Percent
-1.3889
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-09
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.69
Earnings History > 12 > eps Estimate
-0.62
Earnings History > 12 > eps Difference
-0.07
Earnings History > 12 > surprise Percent
-11.2903
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-08
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.62
Earnings History > 13 > eps Estimate
-0.62
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
0
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-09
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.66
Earnings History > 14 > eps Estimate
-0.59
Earnings History > 14 > eps Difference
-0.07
Earnings History > 14 > surprise Percent
-11.8644
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-09
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.65
Earnings History > 15 > eps Estimate
-0.52
Earnings History > 15 > eps Difference
-0.13
Earnings History > 15 > surprise Percent
-25
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-10
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.74
Earnings History > 16 > eps Estimate
-0.49
Earnings History > 16 > eps Difference
-0.25
Earnings History > 16 > surprise Percent
-51.0204
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-09
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.71
Earnings History > 17 > eps Estimate
-0.67
Earnings History > 17 > eps Difference
-0.04
Earnings History > 17 > surprise Percent
-5.9701
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-10
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.63
Earnings History > 18 > eps Estimate
-0.63
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
0
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-11
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.62
Earnings History > 19 > eps Estimate
-0.63
Earnings History > 19 > eps Difference
0.01
Earnings History > 19 > surprise Percent
1.5873
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-18
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-1.86
Earnings History > 20 > eps Estimate
-0.45
Earnings History > 20 > eps Difference
-1.41
Earnings History > 20 > surprise Percent
-313.3333
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-12-04
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-3.12
Earnings History > 21 > eps Estimate
-1.72
Earnings History > 21 > eps Difference
-1.4
Earnings History > 21 > surprise Percent
-81.3953
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-09-02
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-1.29
Earnings History > 22 > eps Estimate
-2.42
Earnings History > 22 > eps Difference
1.13
Earnings History > 22 > surprise Percent
46.6942
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is also developing therapies for mutant cancers, such as androgen receptor, positive prostate cancer, bladder cancer, Non-Small Cell Lung (NSCLC), as well as various lymphomas and leukemias; melanoma, endometrial, gastric, breast, colorectal, and pancreatic cancers; and dependent cancers, including prostate cancer and diffuse large b-cell lymphoma. The company has collaboration agreement with Eli Lilly and Company for developing FHD-909, a selective ATPase inhibitor of BRM. Foghorn Therapeutics Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AFoghorn Therapeutics (NASDAQ:FHTX) Stock Rating Lowered by Wall Street Zen MarketBeat
Read more →Stifel Initiates Coverage of Foghorn Therapeutics (FHTX) with Buy Recommendation Nasdaq
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$11.7143
Analyst Picks
Strong Buy
5
Buy
2
Hold
1
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 82.15% of the total shares of Foghorn Therapeutics Inc
1.
Flagship Ventures Management, Inc.(22.4202%)
since
2025/06/30
2.
FMR Inc(9.7904%)
since
2025/06/30
3.
Bvf Inc(9.3791%)
since
2025/06/30
4.
Deerfield Management Co(5.7589%)
since
2025/06/30
5.
Fidelity Growth Compy Commingled Pl S(4.7643%)
since
2025/07/31
6.
BlackRock Inc(3.9433%)
since
2025/06/30
7.
Vanguard Group Inc(3.3339%)
since
2025/06/30
8.
Fidelity Growth Company Fund(3.2714%)
since
2025/07/31
9.
Euclidean Capital LLC(2.7839%)
since
2025/06/30
10.
Vanguard Total Stock Mkt Idx Inv(1.8208%)
since
2025/07/31
11.
Geode Capital Management, LLC(1.4288%)
since
2025/06/30
12.
Siren, L.L.C.(1.2749%)
since
2025/06/30
13.
iShares Russell 2000 ETF(1.2691%)
since
2025/08/31
14.
Point72 Asset Management, L.P.(1.1829%)
since
2025/06/30
15.
State Street Corp(0.9617%)
since
2025/06/30
16.
Fidelity Growth Company K6(0.9455%)
since
2025/07/31
17.
Alphabet Inc(0.8861%)
since
2025/06/30
18.
Fidelity Series Growth Company(0.6496%)
since
2025/07/31
19.
Vanguard Institutional Extnd Mkt Idx Tr(0.6446%)
since
2025/07/31
20.
Fidelity Small Cap Index(0.585%)
since
2025/06/30
21.
Birchview Capital, LP(0.55%)
since
2025/06/30
22.
Dafna Capital Management LLC(0.5315%)
since
2025/06/30
23.
Northern Trust Corp(0.5072%)
since
2025/06/30
24.
iShares Russell 2000 Growth ETF(0.3424%)
since
2025/08/31
25.
Jacobs Levy Equity Management, Inc.(0.3408%)
since
2025/06/30
26.
Fidelity Extended Market Index(0.3302%)
since
2025/07/31
27.
iShares Biotechnology ETF(0.3013%)
since
2025/08/31
28.
Vanguard Russell 2000 ETF(0.2763%)
since
2025/07/31
29.
Sio Capital Management, LLC(0.2174%)
since
2025/06/30
30.
Wellington Management Company LLP(0.2093%)
since
2025/06/30
31.
Ameriprise Financial Inc(0.1985%)
since
2025/06/30
32.
Scs Capital Management LLC(0.1892%)
since
2025/06/30
33.
Schwab Small Cap Index(0.1454%)
since
2025/07/31
34.
iShares Russell 2000 Value ETF(0.143%)
since
2025/08/31
35.
NT R2000 Index Fund - NL(0.1401%)
since
2025/06/30
36.
State St Russell Sm Cap® Indx SL Cl I(0.1364%)
since
2025/08/31
37.
iShares Micro-Cap ETF(0.1311%)
since
2025/08/31
38.
Fidelity Select Biotechnology(0.1299%)
since
2025/07/31
39.
Extended Equity Market Fund K(0.1203%)
since
2025/06/30
40.
NT R2000 Index Fund - DC - NL - 3(0.1117%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.2571
Date
2025-09-30
EPS Actual
-0.25
EPS Estimate
-0.3333
EPS Difference
0.0833
Surprise Percent
24.9925%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.